6996.HK
Price:
$4.05
Market Cap:
$2.24B
Antengene Corporation Limited, a biopharmaceutical company, engages in the development of oncology therapies in China. It offers ATG-016, a second generation XPO1 inhibitor, which is in Phase I/II clinical study in patients with solid tumors; ATG-527 (Verdinexor) that has completed Phase I evaluation for chronic human viral infections; ATG-019, a dual PAK4/NAMPT inhibitor for the treatment of NHL and advanced solid tumors; ATG-017, an ERK1/2 inhibitor for the treatment of advanced solid tumors and hematologic malignancies; ATG-010 (selinexor), a SINE compound targeting XPO1; and ATG-101, a PD-L1/4-1BB bispecific antibody, which is in Phase I study for patients with metastatic/advanced solid ...[Read more]
Industry
Biotechnology
IPO Date
2020-11-20
Stock Exchange
HKSE
Ticker
6996.HK
According to Antengene Corporation Limited’s latest financial reports and current stock price. The company's current ROE is -28.27%. This represents a change of 48.29% compared to the average of -19.07% of the last 4 quarters.
The mean historical ROE of Antengene Corporation Limited over the last ten years is -14.73%. The current -28.27% ROE has changed 91.87% with respect to the historical average. Over the past ten years (40 quarters), 6996.HK's ROE was at its highest in in the December 2018 quarter at 51.17%. The ROE was at its lowest in in the December 2020 quarter at -66.39%.
Average
-14.73%
Median
-35.11%
Minimum
-96.42%
Maximum
92.02%
Discovering the peaks and valleys of Antengene Corporation Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.28%
Maximum Annual ROE = 92.02%
Minimum Annual Increase = -285.73%
Minimum Annual ROE = -96.42%
| Year | ROE | Change |
|---|---|---|
| 2024 | -37.52% | -25.92% |
| 2023 | -50.65% | 44.28% |
| 2022 | -35.11% | 28.23% |
| 2021 | -27.38% | -71.60% |
| 2020 | -96.42% | -285.73% |
| 2019 | 51.91% | -43.59% |
The current ROE of Antengene Corporation Limited (6996.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-41.09%
5-year avg
-49.42%
10-year avg
-14.73%
Antengene Corporation Limited’s ROE is greater than Jiangsu Recbio Technology Co., Ltd. (-184.99%), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-49.89%), less than Clover Biopharmaceuticals, Ltd. (54.43%), greater than SinoMab BioScience Limited (-66.18%), greater than Cutia Therapeutics (-54.56%), less than HighTide Therapeutics Inc (-0.08%), greater than Shanghai Bio-heart Biological Technology Co., Ltd. (-15.70%), greater than 3D Medicines Inc. (-22.45%), less than Jacobson Pharma Corporation Limited (12.32%), greater than Mabpharm Limited (-29.27%),
| Company | ROE | Market cap |
|---|---|---|
| -184.99% | $2.38B | |
| -49.89% | $2.49B | |
| 54.43% | $3.13B | |
| -66.18% | $1.78B | |
| -54.56% | $1.69B | |
| -0.08% | $1.50B | |
| -15.70% | $1.33B | |
| -22.45% | $1.09B | |
| 12.32% | $2.49B | |
| -29.27% | $2.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antengene Corporation Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Antengene Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Antengene Corporation Limited's ROE?
How is the ROE calculated for Antengene Corporation Limited (6996.HK)?
What is the highest ROE for Antengene Corporation Limited (6996.HK)?
What is the 3-year average ROE for Antengene Corporation Limited (6996.HK)?
What is the 5-year average ROE for Antengene Corporation Limited (6996.HK)?
How does the current ROE for Antengene Corporation Limited (6996.HK) compare to its historical average?